Cargando…

Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms

SARS-CoV-2 infection can associate diverse neurological manifestations. Several studies have provided proof to support the theory of neurotropic involvement of SARS-CoV-2. Alpha-synuclein has been described as a native antiviral factor within neurons, and upregulation of this protein can be seen in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blanco-Palmero, V. A., Azcárate-Díaz, F. J., Ruiz-Ortiz, M., Laespada-García, M. I., Rábano-Suárez, P., Méndez-Guerrero, A., Aramendi-Ramos, M., Eguiburu, J. L., Pérez-Rivilla, A., Marchán-López, A., Rubio-Fernández, M., Carro, E., González de la Aleja, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892700/ https://www.ncbi.nlm.nih.gov/pubmed/33606070 http://dx.doi.org/10.1007/s00415-021-10444-6

Ejemplares similares

Preanalytical Stability of CSF Total and Oligomeric Alpha-Synuclein
por: Abdi, Ilham Y., et al.
Publicado: (2021)

Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
por: Majbour, Nour K., et al.
Publicado: (2016)

Low CSF Levels of Both α-Synuclein and the α-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy
por: Wennström, Malin, et al.
Publicado: (2013)

Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies
por: Fairfoul, Graham, et al.
Publicado: (2016)

α-Synuclein as CSF and Blood Biomarker of Dementia with Lewy Bodies
por: Kasuga, Kensaku, et al.
Publicado: (2012)

CSF or serum neurofilament light added to α‐Synuclein panel discriminates Parkinson's from controls
por: Oosterveld, Linda P., et al.
Publicado: (2019)

Blood Contamination in CSF and Its Impact on Quantitative Analysis of Alpha-Synuclein
por: Barkovits, Katalin, et al.
Publicado: (2020)

Relation between Alpha-Synuclein and Core CSF Biomarkers of Alzheimer’s Disease
por: Monge-García, Victoria, et al.
Publicado: (2021)

Interaction of CSF α‐synuclein and amyloid beta in cognition and cortical atrophy
por: Lee, Young‐gun, et al.
Publicado: (2021)

Validity of CSF alpha-synuclein to predict psychosis in prodromal Alzheimer's disease
por: Monge-García, Sonia, et al.
Publicado: (2023)

Elevated LGI1‐IgG CSF index predicts worse neurological outcome
por: Gadoth, Avi, et al.
Publicado: (2018)

Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease
por: Llorens, Franc, et al.
Publicado: (2017)

Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease
por: Majbour, Nour K., et al.
Publicado: (2017)

CSF Presenilin-1 complexes are increased in Alzheimer’s disease
por: García-Ayllón, María-Salud, et al.
Publicado: (2013)

Progressive Neurologic Symptoms in the Setting of HIV: A Rare Case of Neurosymptomatic CSF HIV Escape
por: Eisenmenger, Laura B., et al.
Publicado: (2021)

CSF albumin and immunoglobulin analyses in childhood neurologic disorders
por: Hacohen, Yael, et al.
Publicado: (2014)

CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers
por: Majbour, Nour K., et al.
Publicado: (2020)

Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders
por: Yang, Chengran, et al.
Publicado: (2021)

Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson’s disease and dementia with Lewy bodies
por: Stuendl, Anne, et al.
Publicado: (2016)

Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF
por: Boiten, Walter A., et al.
Publicado: (2020)

Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
por: Parnetti, Lucilla, et al.
Publicado: (2014)

Diagnostic and prognostic performance of CSF α‐synuclein in prion disease in the context of rapidly progressive dementia
por: Mastrangelo, Andrea, et al.
Publicado: (2021)

Linking the phenotype of SNCA Triplication with PET-MRI imaging pattern and alpha-synuclein CSF seeding
por: Wurster, Isabel, et al.
Publicado: (2022)

Syndrome of headache with neurologic deficits and CSF lymphocytosis (HaNDL)
por: Skorobogatykh, K, et al.
Publicado: (2013)

Neurological Assessment and Its Relationship to CSF Biomarkers in Amateur Boxers
por: Neselius, Sanna, et al.
Publicado: (2014)

Classification of neurological diseases using multi-dimensional CSF analysis
por: Gross, Catharina C, et al.
Publicado: (2021)

Mechanical vibration does not systematically reduce the tremor in essential tremor patients
por: Lora-Millán, Julio Salvador, et al.
Publicado: (2019)

A rapid α‐synuclein seed assay of Parkinson’s disease CSF panel shows high diagnostic accuracy
por: Orrù, Christina D., et al.
Publicado: (2020)

The p75 neurotrophin receptor localization in blood-CSF barrier: expression in choroid plexus epithelium
por: Spuch, Carlos, et al.
Publicado: (2011)

CSF total tau/α-synuclein ratio improved the diagnostic performance for Alzheimer’s disease as an indicator of tau phosphorylation
por: Shim, Kyu Hwan, et al.
Publicado: (2020)

New evidence on α-synuclein and Tau binding to conformation and sequence specific GC* rich DNA: Relevance to neurological disorders
por: Vasudevaraju, P., et al.
Publicado: (2012)

Fatal cerebral edema associated with serine deficiency in CSF
por: Keularts, Irene M. L. W., et al.
Publicado: (2010)

Spontaneous CSF Collection in the Cervical Spine may Cause Neurological Deficit and Intra-cranial Hypotension
por: Zakaria, Rasheed, et al.
Publicado: (2013)

Evaluation of Alpha-Synuclein Cerebrospinal Fluid Levels in Several Neurological Disorders
por: Agnello, Luisa, et al.
Publicado: (2022)

Choroid Plexus Aquaporins in CSF Homeostasis and the Glymphatic System: Their Relevance for Alzheimer’s Disease
por: Municio, Cristina, et al.
Publicado: (2023)

Increased YKL-40 but Not C-Reactive Protein Levels in Patients with Alzheimer’s Disease
por: Blanco-Palmero, Víctor Antonio, et al.
Publicado: (2021)

Immunopathogenic CSF TCR repertoire signatures in virus-associated neurologic disease
por: Nozuma, Satoshi, et al.
Publicado: (2021)

The synucleins
por: George, Julia M
Publicado: (2002)

A role for G-CSF and GM-CSF in nonmyeloid cancers
por: Aliper, Alexander M, et al.
Publicado: (2014)

Alpha-Synuclein in Peripheral Tissues as a Possible Marker for Neurological Diseases and Other Medical Conditions
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3scmq5fjt1uk9tvov8i0snbnjl